SpeechVive Device for Parkinson's Hypophonia

About SpeechVive

SpeechVive, founded in 2011 and based in West Lafayette, Indiana, commercializes a novel wearable device to treat speech impairment (hypophonia) in Parkinson's disease. Its technology leverages a well-established neurobehavioral phenomenon, the Lombard effect, where background noise prompts the brain to automatically increase vocal effort. The company has achieved regulatory clearance, insurance reimbursement, and commercial traction, positioning it as a non-pharmacological, device-based solution in the neurology and digital health space. Currently, the company is navigating a temporary supply chain disruption that has paused new orders.

Therapeutic Areas